Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin

被引:33
作者
Li, Z
Rodríguez-Iturbe, B
Ni, Z
Shahkarami, A
Sepassi, L
Vaziri, ND [1 ]
机构
[1] UCI, Ctr Med, Div Nephrol & Hypertens, 101 City Dr,Bldg 53,Rm 125,Rt 81, Orange, CA 92868 USA
[2] Univ Zulia, Inst Invest Biomed, Univ Hosp, Renal Serv, Maracaibo 4011, Venezuela
关键词
nitric oxide; atherosclerosis; glomerulosclerosis; metabolic syndrome; insulin resistance; obesity; endothelial function;
D O I
10.1111/j.1523-1755.2005.00747.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Obesity has emerged as a major cause of diabetes, cardiovascular disease, and renal insufficiency worldwide. Obese Zucker rats exhibit hyperphagia, obesity, insulin resistance, hyperlipidemia, and glomerulosclerosis and are frequently used as a model to study hereditary form of metabolic syndrome. Nitric oxide plays a major role in preservation of renal function and structure. The present study was designed to test the hypothesis that renal disease in this model may be associated with down-regulation of endothelial (eNOS) and neuromal NO synthases (nNOS) in the kidney. The study further sought to explore expressions of caveolin-1, phospho AKt, and calmodulin, which regulate activities of constituitive NOS isoforms, as well as soluble guanylate cyclase (sGC), which is involved in NO signaling. Methods. Twenty-two-week-old male obese and lean Zucker rats were studied. Body weight, serum lipids, urine albumin excretion, and renal tissue abundance of the above proteins were determined. Results. Serum glucose and arterial pressure were unchanged, whereas urinary NO metabolite (NO chi) excretion and renal tissue nitrotyrosine abundance were markedly reduced (denoting depressed NO production) in the obese versus lean Zucker rats. This was accompanied by significant glomerulosclerosis, tubulointerstitial damage, renal immune cell infiltration, marked down-regulations of renal tissue eNOS and nNOS, mild reduction of caveolin-1, and unchanged calmodulin, phospho-AKt, and sGC. Conclusion. Hereditary obesity can result in down-regulations of kidney eNOS and nNOS, marked reduction of NO production, and glomerulosclerosis prior to the onset of frank diabetes and hypertension.
引用
收藏
页码:2766 / 2772
页数:7
相关论文
共 44 条
[1]   Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells [J].
Alvarez, V ;
Quiroz, Y ;
Nava, M ;
Pons, H ;
Rodríguez-Iturbe, B .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (05) :F1132-F1141
[2]   A PROSPECTIVE-STUDY OF NUTRITIONAL FACTORS AND HYPERTENSION AMONG UNITED-STATES MEN [J].
ASCHERIO, A ;
RIMM, EB ;
GIOVANNUCCI, EL ;
COLDITZ, GA ;
ROSNER, B ;
WILLETT, WC ;
SACKS, F ;
STAMPFER, MJ .
CIRCULATION, 1992, 86 (05) :1475-1484
[3]   Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes [J].
Coimbra, TM ;
Janssen, U ;
Gröne, HJ ;
Ostendorf, T ;
Kunter, U ;
Schmidt, H ;
Brabant, G ;
Floege, J .
KIDNEY INTERNATIONAL, 2000, 57 (01) :167-182
[4]   Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression [J].
Ding, YX ;
Vaziri, ND ;
Coulson, R ;
Kamanna, VS ;
Roh, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (01) :E11-E17
[5]  
FRUHECK G, 1999, DIABETES, V46, P903
[6]  
Gabbai FB, 1999, SEMIN NEPHROL, V19, P242
[7]   Brief periods of hyperphagia cause renal injury in the obese Zucker rat [J].
Gades, MD ;
van Goor, H ;
Kaysen, GA ;
Johnson, PR ;
Horwitz, BA ;
Stern, JS .
KIDNEY INTERNATIONAL, 1999, 56 (05) :1779-1787
[8]   Evidence for a functional nitric oxide synthase system in brown adipocyte nucleus [J].
Giordano, A ;
Tonello, C ;
Bulbarelli, A ;
Cozzi, V ;
Cinti, S ;
Carruba, MO ;
Nisoli, E .
FEBS LETTERS, 2002, 514 (2-3) :135-140
[9]   RENAL AND CARDIOVASCULAR MECHANISMS OF HYPERTENSION IN OBESITY [J].
HALL, JE .
HYPERTENSION, 1994, 23 (03) :381-394
[10]   OBESITY AND HYPERTENSION [J].
HSUEH, WA ;
BUCHANAN, TA .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (02) :405-427